Beta receptor blockers/ agonists Flashcards
Propranolol
non-selective B-blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
2) ↓ gluconeogenesis via 2 blockade in liver
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* renal excretion
Propranolol
non-selective B-blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
2) ↓ gluconeogenesis via 2 blockade in liver
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
Nadolol
non-selective B-blocker
-24 hr half-life; long term BP control
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
2) ↓ gluconeogenesis via 2 blockade in liver
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
Timolol
non-selective B-blocker
Topical: glaucoma (2 block in eye ↓ aqueous humor prod.)
Nadolol
non-selective B-blocker
-24 hr half-life; long term BP control
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
2) ↓ gluconeogenesis via 2 blockade in liver
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* renal excretion
Timolol
non-selective B-blocker
Topical: glaucoma (2 block in eye ↓ aqueous humor prod.)
*renal excretion
Metoprolol
selective B1 blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* metabolized by liver
Atenolol
selective B1 blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* metabolized by liver
Acebutolol
selective B1 blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* metabolized by liver
Esmolol
selective B1 blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* metabolized by liver
**rapid plasma esterase inactivation
Acebutolol
selective B1 blocker/ partial beta agonist
**Increased antihypertensive effects: partial B2 stimulation—> vasodilation and decreased TPR
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* metabolized by liver
Esmolol
selective B1 blocker
Indications:
- Angina
- MI
- SVT
- HTN
- CHF
- Glaucoma
Toxicity:
1) Masks symptom of hypoglycemia!
3) Insulin resistance
4) Abnormal lipid profile
5) Aggravation of Raynauds
* metabolized by liver
**rapid plasma esterase inactivation
Pindolol
B1 blocker/ partial B agonist
-enhanced antihypertensive effects: partial B2 stimulation—> vasodilation and decreased TPR
Pindolol
B1 blocker/ partial B agonist
-enhanced antihypertensive effects: partial B2 stimulation—> vasodilation and decreased TPR
Labetalol
combined alpha/beta blocker
Indications:
- Hypertensive emergencies (IV)
- moderate/severe HTN